Mumps Vaccine Market Expected To Reach $3.5 Billion By 2031 | CAGR Of 5.8%


(MENAFN- EIN Presswire)

Mumps vaccine market Size 2031

Mumps vaccine market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

PORTLAND, OREGON, UNITED STATES, October 26, 2023 /EINPresswire / -- Mumps vaccine market size valued at $2 billion in 2021, and is estimated to reach $3.5 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031. Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine, which offers resistance against measles, mumps, rubella, and varicella (chickenpox).

List of Key Players :
Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc, Actiza Pharmaceuticals, Merck & Co., Inc.

Download Sample Report

Furthermore, the new product launches and product approvals by the public and private players are anticipated to provide a lucrative opportunity for the market. Moreover, vaccine manufacturers are emphasizing on collaboration with organizations including United Nations International Children's Emergency Fund (UNICEF), World Health Organization (WHO), and Global Alliance for Vaccines and Immunization (GAVI) to enhance their vaccination programs in order to reach the maximum population to provide vaccines. This is anticipated to drive the market during the mumps vaccine market forecast period.

In addition, the government and non-government organizations in the developed as well as developing countries are focusing on creating awareness among the population about vaccination and risk associated with unvaccinated population. Various campaigns and drives are arranged by various organizations that further create awareness among the population about the causes and symptoms about mumps infection. As mumps infection is a contagious infection, hence it is necessary to create awareness among the people about the safety and precautions to be taken to avoid severe outbreaks. In addition, the governments have taken initiatives to spread knowledge and information about the vaccination and immunization, which are expected to help in prevention of infection and avoid any serious conditions associated with it. This further expands the market during mumps vaccine market analysis.

For instance, according to the article published in March 2022, by Center for Health Protection (Hong Kong), School Immunization Teams (SIT) under the Centre for Health Protection (CHP) is the vaccination scheme set up to provide immunization services to primary one student, primary five female students, and primary six students in Hong Kong under Hong Kong Childhood Immunization Programme (HKCIP). This scheme focuses on providing health knowledge about immunization in students, school staff, parents, and strengthening their awareness about vaccine-preventable diseases. Thus, such initiatives increases the success rate of various vaccination drives in the country, which further rises the demand for vaccines including the mumps vaccine.

For Purchase Inquiry

Though presence of several factors drives the growth of mumps vaccine market, few factors also act as a restraint to the market. Factors such as excessive cost and complex procedures associated with the manufacturing and development of vaccines provide a hindrance to the growth of the market. In addition, stringent rules and regulations associated with the development and distribution of mumps vaccines act as a restraint to the market.

The mumps vaccine market size is segmented on the basis of age group, distribution channel, and region. By age group, the market is bifurcated into pediatric and adult. The pediatric segment was the highest contributor to the market in the year 2021 and is expected to grow at the fastest CAGR of 6.1% during the forecast period. The growth of the segment is attributed to rise in awareness about the mumps vaccination in pediatric population in the developed and developing regions.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN25102023003118003196ID1107306834


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.